Search
for
Sort by
Research 241–270 of 1000+
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- 25 years of ERβ: a personal journey
- Alopecia - the search for novel agents continues
- Post-finasteride syndrome – does it really exist?
- Spironolactone May Reduce the Risk of Incident Rosacea
- Endocrine disorders and hormonal therapy for adolescent acne
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
- Sulforaphane, L-Menthol, and Dexpanthenol as a Novel Active Cosmetic Ingredient Composition for Relieving Hair Loss Symptoms
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Effects of 5-alpha reductase inhibitors
- Local synthesis and function of neuro-estrogen and neuro-androgen: impact on the hippocampus-related cognition and neuronal plasticity
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Role of Dutasteride in the Treatment of Androgenetic Alopecia
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- Hair Loss in Men and Women
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Antiandrogen Therapy for Skin and Hair Disease
- CLINICAL UPDATES IN HAIR
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- SUMMARIES OF PAPERS
- A Review on Herbal Drugs Used For Hair Growth Promotion
- Skin manifestations of hyperandrogenism: an update
- Formulation and evaluation of beta-sitosterol enriched herbal scalp serum
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society